KITSW Main page
Dept. of Physical Sciences
KITS Warangal
 
Faculty Profile
Address/Contact
Office : Room No. 217, Block-IV
Phone: 0870-2564888
Mobile: 09246893575
Domain E-mail : va.ps@kitsw.ac.in

Alternate E-mail : amar.velidandi@gmail.com
 
Education
B.Sc., Chemistry, Industrial Chemistry and Mathematics, CKM Arts and Science College / Kakatiya University, Warangal, A. P. India.(2003)
M.Sc., Chemistry, National Institute of Technology-Warangal, A. P., India. (2005)
Ph.D., Chemistry, National Institute of Technology-Warangal, A. P., India. (2005)
Dissertation Title: Design, Synthesis, and Biological Activity of Novel Heterocyclic Based Lipids and Dihydropyrazole Derivatives.


Dr. VELIDANDI AMARNATH
ASSISTANT PROFESSOR
PhysicalSciences Department
 
ACADEMIC AFFILIATION
Details

From

To

Name of the Organization

Assistant Professor

May, 2025

Till Date

Kakatiya Institute of Technology & Science, Warangal.
Associate Professor

September 2020

March 2025

Chaitanya Deemed to be University, Hanamakonda, and Telangana
Assistant Professor

August, 2019

December, 2019

National Institute of Technology, Warangal,Telangana
Assistant Professor

August, 2018

August, 2019

Kakatiya University College of Engineering and Technology, Warangal,Telangana
Vice principal and Head

September 2017

July, 2018

Telangana Tribal Welfare Residential Degree College (Men), Karimnagar, Telangana
Lecturer & Head

June, 2013

August, 2017

SR Degree and PG College, Hanamakonda, Warangal, Telangana.
Lecturer

June, 2007

May. 2008

New Science PG college, Hanamakonda, Warangal, Telangana
Lecturer

September, 2006

April, 2007

CKM arts and science college, Warangal, Telangana.
RESEARCH INTERESTS
PUBLICATIONS
Publications  in Refereed Journals

S. No

Details                                                                                                                                               

1

Velidandi, K. K. Gadidasu, and V. S. Patri, ‘Synthesis of novel porphyrin-based lipids and their antibacterial activity’, Med. Chem. Res., vol. 20, no. 7, pp. 1068–1073, Sep. 2011.(ISSN: 1054- 2523, SCI indexed, Scopus Indexed Journal, Impact factor 2.351, Q2).

2

P. Bethanamudi, S. Bandari, K. Sankari, A. Velidandi, and G. V. P. Chandramouli, ‘Synthesis of novel N1 and N2 indazole derivatives’, J. Chem., vol. 9, no. 4, pp. 1676–1682, Jan. 2012., (ISSN: 2090-9071, Scopus Indexed Journal).

3

Velidandi, K. Gadidasu, and V. S. Patri. Synthesis and Evaluation of Novel Benzoxazole, Benzimidazole and Benzthiazole Based Cationic Lipids as Anticancer agents. Research Journal Of Pharmaceutical, Biological and Chemical Sciences. 2015, 6(4), 404-418. (ISSN:0975-8585. Scopus Indexed Journal, Impact factor 0.351).

4

Velidandi, P. Bethanamudi, Vinay Kumar Sthalam, and K. K. Gadidasu. ‘vitro antibacterial activity and docking studies of newer Pyrazole derivatives’, in vitro antibacterial activity and docking studies of newer Pyrazole derivatives, vol. 6, pp. 196–204, 2015. Pharmacophore. 2015, 6(4), 196-204.(ISSN:2229-5402, Web of science, JCR Indexed Journal, Impact factor 0.44).

5

Velidandi,,Bethanamudi and V. Srilakshmi, K. K. Gadidasu ‘Synthesis and Anticancer Activity of Novel Dihydropyrazole and Benzothiazole Conjugates., vol. 7, pp. 29–39, 2016. Research Journal Of Pharmaceutical, Biological, and Chemical Sciences. 2016, 7(3), 29-39.(ISSN:0975- 8585. Scopus Indexed Journal, Impact factor 0.351).

6

V. Muripiti et al., ‘Dramatic influence of the hydroxy functionality of azasugar moiety in the head group region of tocopherol-based cationic lipids on in vitro gene transfection efficacies’, New J Chem, vol. 45, no. 2, pp. 615–627, 2021. DOI: 10.1039/d0nj03717f. (ISSN: 1144-0546, SCI indexed, Scopus Indexed Journal, Impact factor 3.925, Q2).

7

K. Rajeswari, S. Manturthi, K. Sirisha, and A. N. Velidandi, ‘Anchoring and hydrophobic nature of coumarin in newer coumarin based chalcones: Synthesis, in silico, and in vitro cell viability studies’, Russ. J. Bioorganic Chem., vol. 48, no. 3, pp. 636–642, Jun. 2022.(ISSN: 1070-4280, SCI indexed, Scopus Indexed Journal, Impact factor 1.254,Q4).

8

Afreen, S. Manturthi, and A. nath Velidandi, ‘Thiazole- and coumarin-conjugated (β-lactam scaffold) azetidinones synthesis and their substitution effect in in silico, and in vitro cell viability studies’, SCI indexed, Russ. J. Bioorganic Chem., vol. 48, no. 6, pp. 1273–1281, Dec. 2022. . (ISSN: 1070-4280, Scopus Indexed Journal, Impact factor 1.254, Q4).

9

Rakesh, P. Divya, R. Kvn, V. Muripiti, and A. Velidandi, ‘Preparation, in silico studies, in vitro antibacterial and antioxidantal activity of 4,6-disubstituted dihydropyrimidine thiones’, SCI indexed, Russ. J. Bioorganic Chem., vol. 49, no. 1, pp. 76–80, Feb. 2023. . (ISSN: 1070-4280, Scopus Indexed Journal, Impact factor 1.254, Q4)

10

Prashanthi, S. Kavitha, A. Velidandi, and G. Mohan, ‘Tin chloride-mediated grinding method for the synthesis of thiazole and imidazole Schiff bases and their herbicidal activity’, SCI indexed, Russ. J. Org. Chem., vol. 58, no. 9, pp. 1354–1357, Sep. 2022.(ISSN: 1070-4280, Scopus Indexed Journal, Impact factor 0.86,Q4)

11

Rakesh Balije ,A. Prasad, P. Shyam, and A. Nath Velidandi.Preparation, Insilico studies and substitution effect on Larvicidal activity of newer bis oxadiazoles. Rakesh Balije, vol. 59. Springer publication, 2023, pp. 158–163.(ISSN: 1070-4280, SCI indexed, Scopus Indexed Journal, Impact factor 0.86,Q4)

12

Afreen, Shireesha Manturthi,A. Nath Velidandi. Thiazole, Coumarin conjugated (β-lactam scaffold) AzetidinonesSynthesis and their substitution effect in In silico, and In vitro Cell Viability Studies.Russian Journal of Bioorganic Chemistry, 2022, Vol. 48, No. 6, pp. 1273– 1281.doi:10.1134/S1068162022060036(ISSN: 1068-1620, SCI indexed, Scopus Indexed Journal, Impact factor 1.254,Q4).

13

Balije Rakesh, Puskuri Divya, Rajeshwari KVN, Venkanna Muripiti, A. Nath Velidandi. Preparation, Insilico studies, Invitro Antibacterial and Antioxidantal activity of 4,6-di substituted dihydropyrimidine thiones in Russian Journal of Bio Organic Chemistry,49, 76–80 (2023)(Springer publication)DOI:10.1134/S1068162023010247.(ISSN: 1068-1620, SCI indexed, Scopus Indexed Journal, Impact factor 1.254,Q4)

14

Synthesis, In Vitro Antibacterial Activity and Docking Study of Newer Porphyrin Derivatives. Madhavi Latha Duda, A. Nath Velidandi. Neuro Quantology(Anka publication), September 2022, Volume 20 | Issue 9 | Page 2616-2621 | doi: 10.14704/nq.2022.20.9.NQ44306. (ISSN: 1303-5150, Scopus Indexed Journal, Impact factor 0.45)

15

Adaptable Preparation Methods, and Applications of Thiazines, Rajeswari Kannuri, Venkanna Muripiti, Venkatesh Ravula, Shireesha Manturthi4. Srilakshmi Patri, A. Nath Velidandi. Neuro Quantology(Anka publication) | September 2022 | Volume 20 | Issue 9 | Page 2354-2368 | doi: 10.14704/nq.2022.20.9.NQ44276.(ISSN: 1303-5150, Scopus Indexed Journal, Impact factor 0.45).

16

Polyethylene Glycol-mediated Transformation of Aldehydes to Nitriles. Madhavi Latha Duda, A. Nath Velidandi. Neuro Quantology (Anka publication) | September 2022 | Volume 20 | Issue 9 | Page 3031-3034 | doi: 10.14704/nq.2022.20.9.NQ44349. (ISSN: 1303-5150, Scopus Indexed Journal, Impact factor 0.45).

17

Madhavi Latha Duda, A. Nath Velidandi. Halogenation followed by Deformylation of 3- Formylchromones: A Novel Approaches for Synthesis of 3-Halochromones with Oxone and NaX,Results in Chemistry 5 (2023) 100697, Elsevier publication) (https://doi.org/10.1016/j.rechem.2022.100697, SCI indexed, Scopus Indexed Journal, Impact factor 2.3,Q3).

18

Rajeswari Kannuri,Shireesha Manturthi , Venkanna Muripiti , A. Nath Velidandi.Tin Chloride mediated grinding method for preparation of 2,4-disubstituted benzodiazepine scaffolds their Insilico, and Invitro cell viability studies,Russian Journal of Bio Organic Chemistry, 49, 682–688 (2023)(Springer publication).(ISSN: 1068-1620, SCI indexed, Scopus Indexed Journal, Impact factor 1.254, Q4).

19

Rajeswari Kannuri., Manturthi, S. &A. Nath Velidandi. Coumarin (Lipophobic), Thia/Oxa Diazole (Linker), Amino (Anchoring) Conjugated Scaffolds: Synthesis, In Silico, and In Vitro Cell Viability Studies. Russ J Bioorg Chem 49, 993–999 (2023). https://doi.org/10.1134/S1068162023050060.(Springer publication).(ISSN: 1068-1620, SCI indexed, Scopus Indexed Journal, Impact factor 1.254,Q4).

20

Madhavi Latha Duda, A. Nath Velidandi. G.Shyam Prasad."Human Centromere Associated Protein (CENP-A, B, S, N, E) binding potentials of Nitrile compounds: an In-silico study". Research Journal of Biotechnology, Vol. 18 (11)November,2023)Res. J.Biotech. ISSN: 2278-4535,Scopus Indexed Journal, Impact factor 0.3,Q4).

21

Afreen, A. Nath Velidandi. Hamid Ghaffoori Hasan, Kasetti Ashok babu, Uttam Prasad Panigrahy.Preparation, In-silico, And Anti-Oxidant Studies of Oxygen And Sulphur Consisting 1, 5 -Di Aza Bicyclic Compounds.Eur. Chem. Bull. 2023, 12(4), 483-498, doi: 10.31838/ecb/2023.12.4.040. ISSN 2063-5346.

22

Keesari Srinivas, Puttapaka Vijay Kumar, Hemangi Joshi, A. Nath Velidandi. Synthesis, Characterization, and Antibacterial Activity of Novel 2,3-Dihydroxyquinoxaline-5-сarboxamide Derivatives. & Ravinder Manchal . Russ J Bioorg Chem 49, 1068–1075 (2023). https://doi.org/10.1134/S106816202305014X, (ISSN: 1068-1620, SCI indexed, Scopus Indexed Journal, Impact factor 1.254, Q4).

23

Puskuri Divya, Vinitha Badithapuram,A. Nath Velidandi. Preparation, Insilico studies, In-vitro Antioxidantal and Antibacterial activity of 4,6-di substituted dihydropyrimidinethionesaccepted inRussian Journal of Bio Organic Chemistry,on 13 September 2023, SCI indexed, Scopus Indexed Journal, Impact factor 1.254, Q4).

24

Venkanna Muripiti, A. Nath Velidandi. , Yash Paul Sharma, Ramesh Gondru, C.G. Arya, Janardhan Banothu. Targeted gene delivery through receptors with lipid nanoparticles,Journal of Drug Delivery Science and Technology,Volume 93,2024,105457,ISSN 1773- 2247,https://doi.org/10.1016/j.jddst.2024.105457.SCI indexed, Scopus Indexed Journal, Impact factor 5.0), Q1.

25

Afreen, Venkanna Muripiti, Shireesha Manturthi, A. Nath Velidandi. 2, 6-Di Substituted Pyrimidine Based scaffolds: Synthesis, In- silico, and In-vitro Cell Viability Studies. Results in Chemistry 7 (2024) 101425 Elsevier publication) (https://doi.org/10.1016/j.rechem.2024.101425, SCI indexed, Scopus Indexed Journal, Impact factor 2.3,Q3.

26

Madhavilatha Duda, A. Nath Velidandi, Gurram Shyam Prasad,Novel pyrrole- chromone based chalcones: Synthesis and their anti-breast cancer activity: An In-silico study, Results in Chemistry, 2024.101560,https://doi.org/10.1016/j.rechem.2024.101560,SCI indexed, Scopus Indexed Journal, Impact factor 2.3, Q3.
Journal Papers under review:

1

Preparation, In-silico studies, In-vitro Anticancer activity of pyrimidine thione scaffolds, Puskuri Divya, Vinitha Badithapuram, Amarnath Velidandi; submitted to Results in Chemistry

2

Schiff bases consisting Pyrimidine scaffolds: Synthesis, In-silico, In-vitro Anti-bacterial studies, Puskuri Divya,Amarnath Velidandi; submitted to Results in Chemistry

3

Synthetic methods of Thiazole / Imidazole / Coumarin contained Schiff bases by sonicator, hot water bath, stirrer with heating and their computational Studies, Anti-oxidant studies and In-vitro antibacterial activity, Afreen,Nandith Pasunuti,V. Srilekha, A. Veena,Tarasvi Lakum, Amarnath Velidandi; submitted to Current Organic Chemistry.
UGC care list and Peer reviewed Journals:

1

Synthesis and Applications of Few CoumarinAnalogues: A Mini Review. Prasanna Bethanamudi, Suma Sanikommu, Amarnath Velidandi. IJCRT 8, 6, 2020, ISSN: 2320-2882

2

A Short Review on Synthesis of Imidazole Derivatives. Suma Sanikommu, Amarnath Velidandi& Prasanna Bethanamudi. JETIR, 2020, 7, 2 (ISSN-2349-5162).

3

Synthesis of Phenyl Tetrazolyl Hexa Hydropyranochromene Derivatives. Rateesh Vanam, Prasanna Bethanamudi, M Ravinder, Amarnath Velidandi.Der Pharma Chemica, 2021, 13(2): 27-3

4

Synthesis of Newer approach for amide consisting Dihydro furan derivatives. Juluru Bhasker, Amarnath Velidandi, J.P.Paul, Padma Kandukuri. Int. J. Adv. Res. 2022, 10(07), 186-189. International Journal of Adavanced Research, ISSN: 2320-5407

5

Madhavi Latha Duda and Amaranath VelidandiHalochromones their biological activity,Journal of Pharmacy and Drug Research.July-August, 2023, Vol. 2, Issue 01, PP.70-74.

6

Isolation, Selection And Characterization Of Parthenocarpic Fruit Somaclonal Variant In Brinjal (Solanum Melongena L. Var. PPL). Deepika Guduru, Gante SaiVarma, Amaranath Velidandi, T. Christopher Reuben.Journal of Advanced Zoology,ISSN: 0253-7214,Volume 44 Issue S-9 Year 2023 Page 01-09.
Publications in Refereed Conference Proceedings

S.No

Details

1
Madhavi Latha Duda and Amarnath Velidandi.“Adaptable synthetic routes –from aldehydes to Nitriles”KLH/ICIIHS-22/CHE/402.Tailor and Francis publishers,at First International Conference on Impending Inquisitions in Humanities and Sciences (ICIIHS-2022), [PP.435- 442,ISBN: 9781032484068]held on 28-30 November, 2022 organized by the Department of Humanities and Sciences, K L (Deemed-to-be) University, Hyderabad
Publications in Nationaal Conferences:

1

Session Chair & Organising member at Two-day National Conference on “EMERGING TRENDS IN CHEMICAL SYNTHESIS” (ETCS-2023) 06th & 07th October, 2023 Organized by Department of Chemistry, CHAITANYA (DEEMED TO BE UNIVERSITY) Gandipet, Ranga Reddy, Hyderabad-500075
PROFESSIONAL AFFILIATION

S.No

Details

COURSES TAUGHT

Undergraduate Level

     

Courses Taught

Currently Teaching

Course

Semester, Year, Branch

Course

Semester, Year, Branch

   

 

 

Postgraduate Level

 

 

 

 

   

 

 

FDP's / Conferences / Seminar / National Workshops Attended

S. No.

Name of the FDP/Conference / Seminar

Organizing Institution

Schedule of Programme

 

     
PATENT PUBLICATIONS

S. No.

Details

1

Indian patent publication bearing Application Number 202141055004 titled with “Synthesis of novel Hydrazinyl [1,3]-Thiazine derivatives” Inventor & applicant Dr. Amarnath Velidandi, co applicant Mrs. Rajeswari Kannuri. Publication date:10-12-2021

2

Indian patent publication bearing Application Number 202341027536 titled with Isolation of compound from extraction of Erycibe paniculata leaf and their antibacterial activity filed on 14-04-2023. Inventor & applicant Dr. T.Murali, co applicant Dr. Amarnath Velidandi.

3

A system for Extraction and characterization of bio active compound from the Dendrophthae falcata Haustorium.German patent granted [IPC:A61K36/185]on 19-07-2023. Inventor & applicant Dr. T.Murali, co applicant Dr. Amarnath Velidandi.
RESEARCH GUIDANCE

S. No.

Name of the scholar

Title of Thesis/ Area of Research

University

Status

1

KANNURI RAJESWARI
Synthesis and biological evaluation of newer coumarin, thiazine, and diazepine derivatives
Kakatiya University, Warangal

Awarded

2

MADHAVI LATHA DUDA
Synthesis of nitriles, chalcones, porphyrins, chromones and evaluation of their biological activity
Kakatiya University, Warangal

Awarded

3

AFREEN
Synthesis and biological evaluation of novel azetidinone, pyrimidine, diaza bicyclo derivatives
Kakatiya University, Warangal

Awarded

4

BALIJE RAKESH
Synthesis and biological evaluation of novel oxadiazoles and pyrimidine derivatives
Kakatiya University, Warangal

Thesis Submitted

5

PUSKURI DIVYA
Novel thio pyrimidine derivatives synthesis and biological evaluation
Kakatiya University, Warangal

Thesis Submitted

6

KAVETI SHIRISHA
Green synthesis and biological screening of newer 1, 8-napthyridinyl heterocycles
Kakatiya University, Warangal

Pursuing

7

PRAVEEN
Synthesis, In-silico and In-vitro biological evaluation of Novel Benzimidazole, Bicyclo Pentane amide derivatives
Kakatiya University, Warangal

Pursuing

8

SATYANARAYANA
synthetic organic Chemistry &Medicinal chemistry area
Kakatiya University, Warangal

Pursuing

9

THIRUPATHI
synthetic organic Chemistry &Medicinal chemistry area

Pursuing

SPONSORED PROJECTS

S. No.

Details

Value(Rs.)

Status

OTHER INFORMATION

S. No.

Details

1

Advisory member at MTS laboratories, Hyderabad, from 01-01-2020 to till to date

2

Advisory member at Cosmodent Private Limited, Warangal, from 10-05-2021 to till to date
 
Best viewed in browser Internet Explorer 9 or above with screen_Resolution 1280X1024